JP2013537426A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013537426A5 JP2013537426A5 JP2013524945A JP2013524945A JP2013537426A5 JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5 JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013524945 A JP2013524945 A JP 2013524945A JP 2013537426 A5 JP2013537426 A5 JP 2013537426A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- cancer
- item
- orf3
- impaired
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37421510P | 2010-08-16 | 2010-08-16 | |
| US61/374,215 | 2010-08-16 | ||
| PCT/US2011/048005 WO2012024350A2 (en) | 2010-08-16 | 2011-08-16 | Anti-cancer adenoviruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013537426A JP2013537426A (ja) | 2013-10-03 |
| JP2013537426A5 true JP2013537426A5 (enExample) | 2014-09-18 |
| JP5905460B2 JP5905460B2 (ja) | 2016-04-20 |
Family
ID=45605646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524945A Active JP5905460B2 (ja) | 2010-08-16 | 2011-08-16 | 抗がんアデノウイルス |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9187733B2 (enExample) |
| EP (1) | EP2606137B1 (enExample) |
| JP (1) | JP5905460B2 (enExample) |
| KR (1) | KR101667094B1 (enExample) |
| CN (1) | CN103180448B (enExample) |
| AU (1) | AU2011292119B2 (enExample) |
| BR (1) | BR112013003579A2 (enExample) |
| CA (1) | CA2807778C (enExample) |
| SG (1) | SG187785A1 (enExample) |
| WO (1) | WO2012024350A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013003579A2 (pt) * | 2010-08-16 | 2016-06-07 | Salk Inst For Biological Studi | adenovírus, células, e, métodos para tratar câncer |
| CA2867129C (en) * | 2012-03-13 | 2023-11-21 | Salk Institute For Biological Studies | Selective cell targeting using adenovirus and chemical dimers |
| CA2903582C (en) | 2013-03-14 | 2021-06-08 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
| ES2837400T3 (es) | 2015-10-05 | 2021-06-30 | Salk Inst For Biological Studi | Adenovirus sintético con tropismo para los tejidos dañados para su uso en la promoción de la reparación de heridas y regeneración tisular |
| JP7015551B2 (ja) | 2016-02-23 | 2022-02-15 | ソーク インスティテュート フォー バイオロジカル スタディーズ | ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現 |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| CA3045892A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| CA3062591A1 (en) | 2017-05-08 | 2018-11-15 | Gritstone Oncology, Inc. | Alphavirus neoantigen vectors |
| BR112020019942A2 (pt) | 2018-04-09 | 2021-01-26 | Salk Institute For Biological Studies | composições de adenovírus oncolítico com propriedades de replicação aprimoradas |
| MX2021014525A (es) * | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA137094A (en) | 1911-08-31 | 1911-11-28 | Sheppe, Alice L. | Cloth measuring and price calculating machine |
| FR2726285B1 (fr) * | 1994-10-28 | 1996-11-29 | Centre Nat Rech Scient | Adenovirus depourvus de particules contaminantes viables, preparation et utilisation |
| DK1199368T3 (da) * | 1998-07-07 | 2004-04-13 | Transgene Sa | Anvendelse af adenovirus-E4-læserammer til forbedring af ekspression af et gen af interesse |
| EP1083229A1 (en) * | 1999-09-10 | 2001-03-14 | Introgene B.V. | Modified adenoviral vectors for use in gene therapy |
| EP1284294A4 (en) * | 2000-05-26 | 2004-10-13 | Sumitomo Pharma | RECOMBINANT ADENOVIRUS WITH REDUCED SIDE EFFECTS (12/05/01) |
| US20020106382A1 (en) * | 2000-07-14 | 2002-08-08 | Young Charles S.H. | Modified adenovirus and uses thereof |
| US20030220284A1 (en) | 2002-02-22 | 2003-11-27 | Patricia Yotnda | Delivery of adenoviral DNA in a liposomal formulation for treatment of disease |
| WO2003092579A2 (en) | 2002-04-29 | 2003-11-13 | Hadasit Medical Research Services And Development Company Ltd. | Compositions and methods for treating cancer with an oncolytic viral agent |
| US20060099709A1 (en) | 2002-10-01 | 2006-05-11 | Chuan-Yuan Li | Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| WO2005048950A2 (en) | 2003-11-17 | 2005-06-02 | Biomune, Inc. | Tumor and infectious disease therapeutic compositions |
| EP2352516A2 (en) * | 2008-09-26 | 2011-08-10 | Auburn University | Immunization of avians by mucosal administration of non-replicating vectored vaccines |
| BR112013003579A2 (pt) * | 2010-08-16 | 2016-06-07 | Salk Inst For Biological Studi | adenovírus, células, e, métodos para tratar câncer |
-
2011
- 2011-08-16 BR BR112013003579A patent/BR112013003579A2/pt not_active Application Discontinuation
- 2011-08-16 AU AU2011292119A patent/AU2011292119B2/en active Active
- 2011-08-16 CN CN201180050032.7A patent/CN103180448B/zh active Active
- 2011-08-16 EP EP11818698.0A patent/EP2606137B1/en active Active
- 2011-08-16 JP JP2013524945A patent/JP5905460B2/ja active Active
- 2011-08-16 WO PCT/US2011/048005 patent/WO2012024350A2/en not_active Ceased
- 2011-08-16 CA CA2807778A patent/CA2807778C/en active Active
- 2011-08-16 KR KR1020137006526A patent/KR101667094B1/ko active Active
- 2011-08-16 SG SG2013009790A patent/SG187785A1/en unknown
-
2013
- 2013-02-15 US US13/768,933 patent/US9187733B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013537426A5 (enExample) | ||
| Barkauskas et al. | Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis | |
| AR090470A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
| WO2012142529A3 (en) | Clonal strains of attenuated vaccinia viruses and methods of use thereof | |
| BR112016020688A2 (pt) | Composições úteis no tratamento da deficiência da ornitina transcarbamilase (otc) | |
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| SA520412637B1 (ar) | B7 الفيروس الغدي الحال للورم المشفِّر لبروتين | |
| FR2981643B1 (fr) | Procede de preparation d'un materiau composite silicium/carbone, materiau ainsi prepare, et electrode notamment electrode negative, comprenant ce materiau. | |
| WO2015061294A8 (en) | Use of sting agonists to treat chronic hepatitis b virus infection | |
| JP2013530155A5 (enExample) | ||
| NZ748120A (en) | Tri-segmented pichinde viruses as vaccine vectors | |
| BR112014015016A8 (pt) | Proteína homodimérica de duas cadeias de aminoácidos idênticas, cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica, célula hospedeira, método de preparação de uma proteína homodimérica, método para preparação de uma vacina, vacina e método de tratamento ou prevenção | |
| BR112015025464A2 (pt) | coagonistas do receptor de glp-1/glucagon estáveis, prolongados para uso médico | |
| IN2015DN00376A (enExample) | ||
| BR112015008930A2 (pt) | vacinas baseadas em partícula recombinante contra a infecção por citomegalovírus humano | |
| IL187321A (en) | Molecules that have a specific link to a surrogate cell that encode monoclonal antibodies capable of neutralizing viruses, medicinal preparations containing them, and their uses in drug preparation | |
| JP2011157399A5 (enExample) | ||
| BR112018074869A2 (pt) | anticorpos antagonistas que ligam t ao tgfb1, tgfb2 e ao tgfb3 humanos e seu uso para o tratamento de fibrose pulmonar | |
| PH12014500865A1 (en) | Compounds and methods for enhancing innate immune responses | |
| NZ628385A (en) | Batches of recombinant adenovirus with altered terminal ends | |
| JP2018512597A5 (enExample) | ||
| MD4481B1 (ro) | Herpesvirus recombinant Koi (KHV) şi vaccin pentru profilaxia bolii cauzate de KHV | |
| JP2013544892A5 (enExample) | ||
| Hu et al. | Oncolytic viruses for the treatment of bladder cancer: advances, challenges, and prospects | |
| JP2014515258A5 (enExample) |